Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

New cytokine-targeted therapies show promise for treating alopecia areata.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Wnt5a may contribute to psoriasis by reducing skin cell growth, blocking skin cell maturation, and increasing inflammation.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.